The soy industry and U.S. farmers have much to gain from the commercialization of soybean biotech varieties that increase yield, improve food and feed nutrition, resist disease, offer competition and alternatives in the marketplace, and help manage weed resistance issues.
Photo Courtesy of USB
Given the number of new soybean biotechnology events that biotech providers had committed to bring the next generations of biotech soybeans to the marketplace, the American Soybean Association (ASA) formed the Biotech Working Group (BWG) in 2007. Such a robust pipeline of events requires strong coordination among U.S. soybean farmers and technology providers if new biotech events are to be brought to market in a timely manner while not disrupting domestic or foreign markets.
BWG provides the forum where overarching biotechnology issues (e.g., adventitious presence, U.S. and foreign government regulatory systems, trade and market barriers, education needs) are discussed and addressed by technology providers and U.S. soybean growers.
This group also provides a confidential forum where individual events and company issues (e.g., pre-launch stewardship plans, efforts to seek and obtain regulatory approvals for specific events in the U.S. and foreign export markets) are discussed and addressed by companies and U.S. soybean growers. Action plans are developed as an outgrowth of these discussions.
BWG is comprised of farmer leaders and staff from ASA, United Soybean Board (USB), and U.S. Soybean Export Council (USSEC). Industry members of the Biotech Working Group include BASF, Bayer, Corteva and Syngenta. Meetings are held twice yearly with at least one meeting being held in Washington, D.C.
Email Bill Schuermann